Outcomes of the European Federation of Pharmaceutical Industries and Associations Oligonucleotide Working Group Survey on Nonclinical Practices and Regulatory Expectations for Therapeutic Oligonucleotide Safety AssessmentYann Tessier, Laurence O. Whiteley, Patrik Andersson et al.|Nucleic Acid Therapeutics|2020Cited by 14
Opportunities for More Tailored Approaches to Genotoxicity Testing and Carcinogenicity Strategy for Oligonucleotide Therapeutics: Outcome of an Industry SurveyJoel D. Parry, Yi Yan Yang, Tod A. Harper et al.|Nucleic Acid Therapeutics|2025Cited by 2